“Innovative technology leads the future”, Era Biology closely follows the theme of this exhibition and leads the development of microbial diagnosis to intelligence.
The world’s first au...
From January 2020 to October 2020, a prospective methodological study was conducted at the Pisa University Hospital which published on BMC Microbiology. Goldstream® Fungus (1-3)-β-D-Glucan Test was...
A recent multi-center study on the diagnosis of cryptococcal infections was conducted by the Medical Center of Utrecht University, the Institute of Biodiversity and Ecosystem Dynamics of the Univer...
Tianjin, China – July 28, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and pioneer of invasive fungal disease diagnostic field since 199...
A few days ago, ERA BIO (Suzhou) New Product Launch Conference and Liandong U Valley Signing Ceremony was successfully completed in Suzhou, Jiangsu! At this press conference, Yirui Biological rele...
FungiXpert Cryptococcal Antigen Rapid Test Successfully Approved by Health Canada
We are pleased to announce that our Cryptococcal Capsular Polysaccharide Detection K-Set (Lateral Flow Assay) has b...